These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27959636)

  • 1. Amyloidosis: Insights from Proteomics.
    Dogan A
    Annu Rev Pathol; 2017 Jan; 12():277-304. PubMed ID: 27959636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesis.
    Brambilla F; Lavatelli F; Valentini V; Di Silvestre D; Obici L; Mauri P; Merlini G
    Amyloid; 2012 Jun; 19 Suppl 1():11-3. PubMed ID: 22551153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.
    Larsen BT; Mereuta OM; Dasari S; Fayyaz AU; Theis JD; Vrana JA; Grogan M; Dogan A; Dispenzieri A; Edwards WD; Kurtin PJ; Maleszewski JJ
    Histopathology; 2016 Apr; 68(5):648-56. PubMed ID: 26212778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States.
    Mereuta OM; Theis JD; Vrana JA; Law ME; Grogg KL; Dasari S; Chandan VS; Wu TT; Jimenez-Zepeda VH; Fonseca R; Dispenzieri A; Kurtin PJ; Dogan A
    Blood; 2014 Mar; 123(10):1479-82. PubMed ID: 24415538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis.
    Chandan VS; Shah SS; Lam-Himlin DM; Petris GD; Mereuta OM; Dogan A; Torbenson MS; Wu TT
    Am J Surg Pathol; 2015 Apr; 39(4):558-64. PubMed ID: 25602789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.
    Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Rossi R; Palladini G; Obici L; Verga L; Mauri P; Merlini G
    Blood; 2012 Feb; 119(8):1844-7. PubMed ID: 21917755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis.
    Charalampous C; Dasari S; McPhail E; Theis JD; Vrana JA; Dispenzieri A; Leung N; Muchtar E; Gertz M; Ramirez-Alvarado M; Kourelis T
    Kidney Int; 2024 Mar; 105(3):484-495. PubMed ID: 38096952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pathology of Amyloidosis in Classification: A Review.
    Picken MM
    Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
    Lavatelli F; Perlman DH; Spencer B; Prokaeva T; McComb ME; Théberge R; Connors LH; Bellotti V; Seldin DC; Merlini G; Skinner M; Costello CE
    Mol Cell Proteomics; 2008 Aug; 7(8):1570-83. PubMed ID: 18474516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in protein misfolding diseases.
    Stoppini M; Obici L; Lavatelli F; Giorgetti S; Marchese L; Moratti R; Bellotti V; Merlini G
    Clin Chem Lab Med; 2009; 47(6):627-35. PubMed ID: 19527136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification of amyloidosis].
    Misumi Y; Ando Y
    Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Distribution in a Mexican Population.
    de la Cruz Jasso MA; Mejía-Vilet JM; Del Toro-Cisneros N; Aguilar-León DE; Morales-Buenrostro LE; Herrera G; Uribe-Uribe NO
    Am J Clin Pathol; 2023 Jan; 159(1):89-97. PubMed ID: 36370056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM structure of a human LECT2 amyloid fibril reveals a network of polar ladders at its core.
    Richards LS; Flores MD; Zink S; Schibrowsky NA; Sawaya MR; Rodriguez JA
    Structure; 2023 Nov; 31(11):1386-1393.e3. PubMed ID: 37657439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte Cell-Derived Chemotaxin-2 Amyloidosis (ALECT2) in a Patient With Lung Adenocarcinoma: An Autopsy Report and Literature Review.
    Tariq H; Sharkey FE
    Int J Surg Pathol; 2018 May; 26(3):271-275. PubMed ID: 29017384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New advances in the subtyping of systemic amyloidosis].
    Sun WY; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic amyloidosis from A (AA) to T (ATTR): a review.
    Muchtar E; Dispenzieri A; Magen H; Grogan M; Mauermann M; McPhail ED; Kurtin PJ; Leung N; Buadi FK; Dingli D; Kumar SK; Gertz MA
    J Intern Med; 2021 Mar; 289(3):268-292. PubMed ID: 32929754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Identification and Clinicopathologic Characterization of Splenic Amyloidosis.
    Chiu A; Dasari S; Kurtin PJ; Theis JD; Vrana JA; Rech KL; Dao LN; Howard MT; Dalland JC; McPhail ED
    Am J Surg Pathol; 2023 Jan; 47(1):74-80. PubMed ID: 35968972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between monoclonal gammopathy and cardiac amyloid type.
    Maleszewski JJ; Murray DL; Dispenzieri A; Grogan M; Pereira NL; Jenkins SM; Judge DP; Caturegli P; Vrana JA; Theis JD; Dogan A; Halushka MK
    Cardiovasc Pathol; 2013; 22(3):189-94. PubMed ID: 23102805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F; Vrana JA
    Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.